Ruedi Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-354
Closed -$31.8K 225
2025
Q1
$31.8K Hold
354
0.01% 106
2024
Q4
$35.3K Hold
354
0.01% 99
2024
Q3
$40.3K Sell
354
-43
-11% -$5.11K 0.01% 96
2024
Q2
$49.2K Buy
397
+86
+28% +$11.1K 0.02% 87
2024
Q1
$41.1K Hold
311
0.02% 93
2023
Q4
$34K Hold
311
0.02% 93
2023
Q3
$32.1K Buy
311
+200
+180% +$21.6K 0.02% 93
2023
Q2
$12.9K Hold
111
0.01% 128
2023
Q1
$11.9K Sell
111
-239
-68% -$25.8K 0.01% 146
2022
Q4
$38.9K Buy
+350
New +$35.8K 0.03% 82

Other funds holding MRK

Ruedi Wealth Management's MRK Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Merck (MRK) in Q2 2025, closing a stake of 354 shares — an estimated $31.8K sold.

Ruedi Wealth Management first reported a position in MRK in Q4 2022 and held it in 10 quarters. The position peaked at $49.2K in Q2 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 354 Merck shares in Q2 2025, an estimated $31.8K.
  • Ruedi Wealth Management first reported a position in Merck in Q4 2022 and held it in 10 quarters.
  • Ruedi Wealth Management's Merck position peaked at $49.2K in Q2 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.